Our promise to you:
Guaranteed product quality, expert customer support.
24x7 CUSTOMER SERVICE
CONTACT US TO ORDER
Creative Biogene responded quickly to the monkeypox pandemic epidemic. Creative Biogene, using its rapid development platform based on immunological raw materials, provides high-quality and comprehensive virus detection, antibodies, antigens, and nucleic acid materials in the field of monkeypox virus, supporting scientists in expediting product development.
Since May 2022, monkeypox cases have been reported in several non-endemic countries and have quickly spread to regions worldwide. From early 2024 to the end of July, Africa reported over 14,500 infection cases and 450 deaths, up 160% and 19%, respectively, from the same period last year. On August 14, 2024, the WHO declared the monkeypox outbreak a "Public Health Emergency of International Concern," the highest level of global health alert under the International Health Regulations. The WHO's alert emphasizes the significance of ongoing monitoring and response to the monkeypox virus to avoid future spread and reduce its impact on global public health.
The monkeypox virus belongs to the Orthopoxvirus genus and is a double-stranded DNA virus. It is mainly classified into Clade I (Congo Basin group) and Clade II (West African group), with Clade I associated with more severe disease. The genome encodes around 200 proteins, including several structural and functional proteins. Proteins like A29L, A35R, E8L, and B21R are important targets for diagnostics and vaccine development. Scientists are exploiting these insights to produce diagnostic reagents, treatments, and vaccinations
Creative Biogene collaborates closely with researchers worldwide, offering supportive services and products to both academia and industry. Our services and products range from plasmids, nucleic acid detection kits, and antigen/antibody rapid detection kits to pseudoviruses. Additionally, we provide customized services and products tailored to your specific needs.
Creative Biogene offers a range of real-time PCR kits and rapid test kits for the quick and accurate detection of monkeypox virus antigens and antibodies, enabling fast identification of infections.
Creative Biogene supplies a range of monoclonal antibodies and recombinant proteins related to the monkeypox virus for diagnostic development.
Creative Biogene is dedicated to being customer-focused, always improving technology and developing products to give more precise and efficient in vitro diagnostic solutions for consumers worldwide. The debut of our monkeypox virus detection products efficiently assists countries in virus detection, allowing for rapid diagnosis and control of monkeypox. In the future, the company plans to enhance in vitro diagnostic technology, benefiting worldwide public health. If you are interested in our services, please contact us.
Copyright © Creative Biogene. All rights reserved.